Studie viser signifikant forbedring af blæretømning med Coloplasts Luja™ sammenlignet med konkurrentkateter
31 mars 2023 01h55 HE
|
Coloplast A/S
Studieresultater viser, at Coloplasts nye engangskateter med mere end 80 mikrohuller, Luja, opnåede fuldstændig blæretømning i frit flow* i 90% af kateteriseringerne, mens Hollister’s VaPro™ med to...
Study shows significant improvement in bladder emptying with Coloplast's Luja™ compared to competitor catheter
31 mars 2023 01h55 HE
|
Coloplast A/S
Study results show that Coloplast’s new intermittent male catheter with 80+ micro-holes, Luja, achieved complete bladder emptying in one free flow* in 90% of catheterisations, while Hollister’s...
Coloplast lancerer nyt kateter til mænd udviklet til at mindske risikoen for urinvejsinfektioner
03 févr. 2023 01h35 HE
|
Coloplast A/S
Det nye intermitterende kateter, Luja™, adresserer betydelige risikofaktorer for urinvejsinfektioner, som er en byrde for mennesker, der bruger intermitterende katetre samt sundhedssystemer verden...
Coloplast launches male catheter designed to reduce the risk of urinary tract infections
03 févr. 2023 01h35 HE
|
Coloplast A/S
The new intermittent catheter Luja™ addresses important risk factors for urinary tract infections, a significant burden for people using intermittent catheters as well as healthcare systems as a...
Coloplast Launches New Catheter in the U.S.
18 nov. 2022 10h00 HE
|
Coloplast A/S
Coloplast’s SpeediCath® Flex Set catheter developed for people living with bladder and urinary problems is now cleared in the U.S. and will be launched in November 2022. The new SpeediCath Flex Set...
Coloplast udnævner ny chef for den globale urologiforretning
15 nov. 2022 10h00 HE
|
Coloplast A/S
Den 2. januar 2023 overtager Tommy Johns stillingen som ansvarlig for Coloplasts globale urologiforretning. Tommy Johns tager over efter Steve Blum, der har besluttet at gå på pension ved dette års...
Coloplast appoints new President of its global Interventional Urology business
15 nov. 2022 10h00 HE
|
Coloplast A/S
Effective January 2, 2023, Tommy Johns will enter a new role as President & Senior Vice President of Coloplast’s global Interventional Urology (IU) business, replacing Steve Blum, who has decided...
Coloplast launches Saffron™ Fixation System for Prolapse Repair
06 oct. 2022 10h00 HE
|
Coloplast A/S
Coloplast is introducing the Saffron™ Fixation System designed for ease and reliability during pelvic floor reconstruction for women who suffer from pelvic organ prolapse (POP). “Our goal...
Coloplast leverer solidt 2. kvartal med 7% organisk vækst og en overskudsgrad på 31% og justerer forventningerne til den organiske vækst for 2021/22 til 6-7% fra omkring 7%
05 mai 2022 06h05 HE
|
Coloplast A/S
Forventningerne til den rapporterede vækst og den rapporterede overskudsgrad før særlige poster fastholdes på hhv. omkring 15% og omkring 31%. Den rapporterede omsætning målt i danske kroner steg 16%...
Coloplast delivers a solid Q2 with 7% organic growth and a 31% EBIT margin and revises full year organic growth guidance to 6-7% from around 7%
05 mai 2022 06h05 HE
|
Coloplast A/S
The company maintains its reported growth guidance of around 15% and reported EBIT margin guidance of around 31% before special items. Reported revenue in DKK was up by 16% in Q2. EBIT before special...